Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Catherine P. Leith(University of Wisconsin Carbone Cancer Center), Cheryl L. Willman(Mayo Clinic)
Cited by 579
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia
|New England Journal of Medicine|1997|1.1k
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
|Nature Materials|2011|1k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934